Dudediligence.

Werewolf Therapeutics, Inc

HOWLNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$16.7MSep ’24−$20.4MDec ’24−$18.1MMar ’25−$18.0MJun ’25−$16.4MSep ’25−$8.4MDec ’25−$13.5MMar ’26$3.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$50.1M−$56.1M−$40.5M−$73.6M−$60.7M
Net income−$50.0M−$53.8M−$37.4M−$70.5M−$60.8M
Operating cash flow−$42.9M−$40.6M−$32.6M−$56.2M−$60.3M
Free cash flow−$43.4M−$44.2M−$33.4M−$56.4M−$60.3M
Cash$157.5M$129.3M$134.3M$111.0M$57.0M
Debtnone on filenone on file$40.0M$32.1M$32.1M
Shares outstanding27.3M31.4M39.1M44.8M48.6M